Pluristem Therapeutics, Inc. (PSTI) Social Stream
Pluristem Therapeutics Inc (PSTI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Pluristem Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PSTI's average price target has moved up $0.1 over the prior 13 months.
Over the past 47 weeks, PSTI's average upside potential has been 172.25%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PSTI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 123 days, PSTI's average broker recommendation rating improved by 0.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Pluristem Therapeutics Inc's variance in analysts' estimates is lower than -87.94% of them.
- Pluristem Therapeutics Inc's average analyst price target is higher than 14.3% of all US stocks.
- PSTI has a greater upside potential (average analyst target price relative to current price) than 185.66% of all US stocks.
- In the context of stocks in the micro market cap category, Pluristem Therapeutics Inc's number of analysts covering the stock is higher than 163.81% of them.
In the Pharmaceutical Products industry, PMCB, PHGE, and MIRO are the three stocks most similar to Pluristem Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is PSTI a Buy, Hold or Sell? See the POWR Ratings now!